Prednisolone Sodium Phosphate/Sulfacetamide Sodium

泼尼松龙磷酸钠/磺胺醋酰钠

Report date: 2022/01/24 09:14:46

Base Information

Drug NamePrednisolone Sodium Phosphate/Sulfacetamide Sodium
Drug Alias NameSulfacetamide/Prednisolone Sodium Phosphate磺胺醋酰钠/泼尼松龙磷酸钠Sulfacetamide Sodium/Prednisolone Sodium PhosphateSulfacetamide sodium + Prednisolone sodium phosphatePrednisolone Sodium Phosphate and Sulfacetamide Sodium +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionDihydropteroate synthase inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorDihydropteroate synthase
Therapy Area/IndicationsOcular inflammationEye Infections
Global Approved IndicationsOcular inflammationEye Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1988/08/26
Country/TerritoryUnited States
CombinationsYes Sulfacetamide SodiumPrednisolone Sodium Phosphate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsOcular inflammationEye Infections

Other Information

ATC CodeR01AD52
Related LinksN/A